REGN - Company ID 0000872589
The table below shows REGENERON PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.66B | $2.46B | $2.96B | $2.51B | $2.00B | $3.09B |
| Short-term investments | $5.64B | $5.54B | $5.79B | $5.94B | $5.47B | $5.26B |
| Receivables | $7.58B | $6.57B | $5.73B | $5.69B | $5.61B | $5.56B |
| Inventory | $2.89B | $3.08B | $3.10B | $3.25B | $3.21B | $3.19B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $20.80B |
| $18.45B |
| $18.21B |
| $17.98B |
| $16.86B |
| $17.57B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $44.41B | $41.73B | $40.87B | $40.17B | $38.22B | $37.55B |
| Accounts payable | $1.14B | $1.16B | $1.03B | $903.80M | $723.90M | $705.50M |
| Total current liabilities | $6.20B | $5.53B | $5.11B | $4.43B | $3.67B | $3.57B |
| Long-term debt | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | $1.98B |
| Total liabilities | $10.91B | $10.02B | $9.45B | $9.21B | $8.28B | $8.16B |
| Retained earnings | $39.47B | $37.62B | $36.42B | $35.05B | $33.68B | $32.38B |
| Total equity | $33.50B | $31.71B | $31.42B | $30.96B | $29.94B | $29.39B |